Pharmacokinetics (PK) and safety of enzalutamide in healthy Chinese males.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e14073
Abstract: e14073Background: Enzalutamide (ENZ), an androgen receptor inhibitor, is approved in over 60 countries except China for use in metastatic castration-resistant prostate cancer. The PK of ENZ have be... read more here.
Keywords: safety enzalutamide; healthy chinese; chinese males; enzalutamide healthy ... See more keywords